Table 4.
Outcome measures and complications*
| Reference | Postoperative incision intervention group(s) (No. of incisions) | Infection, % | Dehiscence, % | Seroma; hematoma, % | Skin necrosis; Skin blistering, % | Reoperation, % | Time to dry wound, d |
|---|---|---|---|---|---|---|---|
| Stannard et al14 | SDD (n = 24) | 3 (12.5) | 4 (16.7) | 4.8 d‡ | NR; NR | NR | 3.1 |
| INPWT (n = 20) | 3 (15) | 4 (20) | 1.8 d‡ (P = .02) | NR; NR | NR | 1.6 (P = .03) | |
| Reddix et al18 | NAG + INPWT (n = 19) | 0 | 0 | NR; NR | NR; NR | NR | NR |
| Atkins et al16 | NAG + Silver foam INPWT (n = 57) | 0 | NR | NR; NR | NR; NR | 0 | NR |
| Goldstein et al20 | INPWT (n = 17) | 0 | 2 (11.8) | NR; NR | NR; NR | NR | NR |
| Pachowsky et al13 | SDD (n = 10) | NR | NR | 9 (90); NR | NR; NR | NR | NR |
| INPWT† (n = 9) | NR | NR | 4 (44) (P = .021); NR | NR; NR | NR | NR | |
| Colli and Camara19 | INPWT† (n = 10) | 0 | 0 | NR; NR | NR; NR | 0 | 5 |
| Howell et al11 | SDD (n = 36) | 1 (2.8) | NR | NR; NR | NR; 3 (12) | 0 | 4.1 |
| INPWT (n = 24) | 1 (4.2) | NR | NR; NR | NR; 15 (63) | 0 | 4.3 | |
| Masden et al12 | SDD (n = 37) | 5 (13.5) | 11 (29.7) | NR; NR | NR; NR | 8 (22) | 4.1 |
| NAG + INPWT (n = 44) | 3 (6.8) | 16 (36.4) | NR; NR | NR; NR | 9 (21) | 4.3 | |
| Stannard et al15 | SDD (n = 122) | 23 (18.9) | 20 (16.5) | NR; NR | NR; NR | NR | 3 |
| INPWT (n = 141) | 14 (9.9) (P = .049) | 12 (8.6) (P = .044) | NR; NR | NR; NR | NR | 2.5 | |
| SDD (n = 33) | 2 (6) | 13 (39) | 4 (12); 0 | 6 (18); NR | NR | NR | |
| Conde-Green et al17 | NAG + INPWT (n = 23) | 1 (4.3) | 2 (8.7) (P = .014) | 0; 0 | 2 (8.7); NR | NR | NR |
*Abbreviations are explained in the first footnote to Table 3.
†Prevena incisional negative pressure wound therapy system (Kinetic Concepts Inc, San Antonio, Texas).
‡Days of drainage from incision greater than minimal (>2 quarter-sized drops of drainage).